Validation in the Cloud: ELNs and SaaS Compliance | Revvity Signals
Navigating Validation in the Cloud: Staying Compliant without Slowing Down
Today, research and development teams are increasingly attracted to electronic notebook (ELN) SaaS for capabilities like rapid feature delivery and easier collaboration across sites, with less infrastructure to manage. This adds new pressure to IT compliance, QA and regulatory validation teams. In regulated R&D, these teams are tasked with proving that every system is controlled, validated, and fit for purpose.
Traditional validation is reliable but often seen as an obstacle to innovation, as it tends to be slow, manual, and expensive. This raises the question: can SaaS implementation meet the needs of R&D while also improving on traditional validation?
It requires redesigning validation around the SaaS. If you treat cloud platforms like old on-premises systems, you get the worst of both worlds: R&D teams feel blocked by never-ending validation cycles, and compliance groups worry that fast change will undermine data integrity and audit trails.
Validation in the Cloud
Regulatory requirements did not change just because ELNs have moved to the cloud. GxP-relevant R&D organizations need to have controlled, documented processes and validated computerized systems to ensure scientific data is reliable and reproducible.
FDA criteria for electronic records and signatures are set in 21 CFR Part 11 and intended to ensure trustworthiness and reliability, ultimately for equivalence with paper records and handwritten signatures. It explicitly covers how records are created, modified, maintained, archived, and submitted in regulated environments.
In part this relies on secure, computer-generated, time-stamped audit trails that record who did what, when, and (often) why. The goal is to allow complete reconstruction of changes to regulated data for traceability, accountability, and data integrity reviews. A cloud-based ELN can and must be built for this reality. The right SaaS model shifts much of the technical burden away from internal IT: the vendor owns hosting, security certifications, and baseline IQ/OQ testing on deferred releases, while customers focus on PQ and intended-use validation in their own R&D context.
The Hidden Cost of Legacy Validation Approaches
Most R&D validation playbooks were written for on-prem systems that changed slowly and infrequently. In that world, validation often meant highly manual documentation: writing and re-writing test scripts in Word, printing them for execution, capturing screenshots as evidence, and filing everything away in shared drives. For IT compliance and QA teams, just maintaining the paperwork around each release became a full-time job.
Those same methods also drive long testing cycles, which can include running large, repetitive regression test sets. All of this adds up to high costs and a constant resource drain. Internal specialists who should be focused on strategically supporting research and development workflows are instead trapped in a loop of highly manual tasks.
The irony is that, despite all that effort, legacy approaches still leave gaps:
- Incomplete or inconsistent validation can lead to audit failures
- Missing test evidence, unclear change control, or fragmented audit trails raise the risk of rework and delays or, even worse, regulatory penalties
- Validation, which should protect the business, ends up slowing it down
What Validation-ready SaaS Looks Like
Modern SaaS solutions like Revvity Signals’ Signals Notebook™ and Signals One™ are built with validation readiness as a core design principle rather than an afterthought. System, release process, and documentation are structured so IT compliance teams can keep environments validated without recreating every test from scratch. R&D teams rely on Revvity Signals for much of the heavy lifting.
Signals Notebook and Signals One includes three key features to support compliance:
- Automated documentation: vendor-supplied IQ/OQ evidence, verification summaries, and detailed release notes that describe what changed and how it was tested
- Deferred release cycles for validated environments: give organizations time to plan and execute validation before changes reach production, while still benefiting from regular innovation – Signals Notebook and Signals One updates validated tenants three times a year
- Continuous updates: SaaS architectures enable audit trail enhancements, security improvements and usability refinements, so regulated teams get ongoing data-integrity and compliance benefits without large upgrade projects
Revvity Signals uses this validation-ready approach across for Signals Notebook and Signals One, providing cloud-native solutions that support GxP expectations, including 21 CFR Part 11–aligned electronic records and signatures, robust security, and complete audit trails for experiment content and attached files. Signals Notebook and Signals One allows multi-tenant architecture for sandbox, staging and production, with configurable validation options. For R&D organizations, this means validation is no longer at odds with velocity.
Making Validation Work at the Speed of R&D
Even with validation-ready SaaS, you still need a strategy that fits how your R&D teams actually work. Across Revvity Signals’ customers, several practices consistently help.
- Use a risk-based approach: identify GxP-relevant flows to keep validation aligned with real R&D impact instead of spreading resources thin
- Leverage vendor partnerships: Revvity’s Validation Readiness materials include IQ/OQ packs, release documentation, and validation guidance can reduce the need for in-house efforts
- Periodic audits: Signals Notebook’s built-in audit trails aren’t just for inspectors. They capture who changed what, when, and why so IT compliance can quickly answer, “what happened here?”
Turning Validation from Burden to Advantage
Done right, SaaS solutions like Signals Notebook and Signals One can accelerate compliance, not hinder it. Validation becomes a quiet competitive advantage: you know your systems support your R&D processes, you can prove it at any time, and your audit trails back every critical decision. See Signals Notebook and Signals One in action.
Ready to leverage validation as a strategic enabler? Reach out to the Revvity Signals team today.
Diana Tran
Principal Product Marketing Professional for Signals OneDiana Tran leverages over 10 years of healthcare and biotech experience in her role as Principal Product Marketing Professional for Signals One at Revvity Signals Software, Inc. She joined Revvity Signals over 5 years ago and is responsible for go-to-market strategy, positioning, and messaging for Signals Notebook and Signals DLX.
Mrs. Tran earned her Bachelor of Science in Pharmaceutical and Health Science from MCPHS University in 2013 and her Master of Science in Global Marketing Management from Boston University. Since then, she has worked across various roles that have allowed her to develop specialized expertise at the intersection of science, technology, and marketing.